US OptionsDetailed Quotes
GENE240920P2500
- 0.95
- 0.000.00%
15min DelayClose Sep 16 15:59 ET
0.00High0.00Low
0.95Open0.95Pre Close0 Volume3 Open Interest2.50Strike Price0.00Turnover819.97%IV-87.88%PremiumSep 20, 2024Expiry Date1.68Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8122Delta0.3867Gamma0.48Leverage Ratio-0.0227Theta-0.0002Rho-0.39Eff Leverage0.0002Vega
Genetic Technologies Stock Discussion
Sign in to post a comment
$Genetic Technologies (GENE.US)$ Genetic Technologies Launches Personalized Risk Testing on EasyDNA Platform
MT Newswires·
Genetic Technologies (ASX:GTG) launched the geneType Risk Assessment portfolio on its EasyDNA platform, according to a Thursday filing with the Australian Securities Exchange.
The availability of geneType on EasyDNA's consumer platform is expected to accelerate global access, potentially reaching 42 countries and generating annual revenues of AU$7.5 million, the filing sa...
MT Newswires·
Genetic Technologies (ASX:GTG) launched the geneType Risk Assessment portfolio on its EasyDNA platform, according to a Thursday filing with the Australian Securities Exchange.
The availability of geneType on EasyDNA's consumer platform is expected to accelerate global access, potentially reaching 42 countries and generating annual revenues of AU$7.5 million, the filing sa...
2
2
$Genetic Technologies (GENE.US)$
NEWS
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
NEWS
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
$Genetic Technologies (GENE.US)$
NEWS
Genetic Technologies Announces $2 Million Registered Direct Offering
NEWS
Genetic Technologies Announces $2 Million Registered Direct Offering
$Genetic Technologies (GENE.US)$ GTG to pilot GeneType in Breast Screen centers across the U.S.
3 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
3 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Genetic Technologies (GENE.US)$ GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
GlobeNewswire· 4 mins ago![]()
GlobeNewswire· 4 mins ago
$Genetic Technologies (GENE.US)$ Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
$Genetic Technologies (GENE.US)$ Damn FINTEL is still showing 150K shares LTB! grr shorts still have power here
No comment yet
Arrayfunction : I was going to say this seemed kinda strange because the US regulators (more FTC than FDA) have always been very strict in how genetic testing companies can advertise and present "health" information. (e.g. 23andme has "pre-dispositions" on "influencing the probability of developing" certain issues).
And a quick Google seems to agree with that - only the sperm related testing is actually coming to the US market. Which might explain why I have only heard of the brand in the context of paternity testing
It will be interesting to see if this is the start of the US letting consumers have more direct access to that kind of information. I am more keen to agree that it's better overall to limit public consumer access.
I haven't kept up with the field in the past decade, but around that time was when the importance of epigenomics and transcriptomics to be shown as playing a significant, if not greater, influence on actual phenotype than strictly genes.
Lnova :
hmm. I will have to check this out. DNA is fascinating 
